BrainLive Connect: Non-professional Delivered CST for People Living With Dementia

Sponsor
The University of Hong Kong
Study ID
NCT07531589
Status
Recruiting
Apply to this trial

Conditions

  • Dementia

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Cognitive Stimulation Therapy (CST) — BEHAVIORAL
    CST has been recognized as an effective and cost-effective intervention for individuals with mild to moderate dementia, leading to improvements in cognition and quality of life. CST is one of the few non-pharmacological interventions recommended by the National Institute for Health and Care Excellence (NICE) in their clinical guideline on dementia, as it has comparable efficacy to anti-dementia drugs. Exercise-enhanced CST is characterised by adding physical exercise into the original group CST protocol. Home2Community CST is characterized by a gradual shift of its intervention site from the participant's home to public space in their neighbourhood and then further to centre-based settings. Living CST is characterised by transferring CST into real life settings to maximise its benefits in daily functioning for independent living.
  • Usual Care — OTHER
    Usual care and support service for people living with dementia in community, including but not limited to, care service, psychosocial intervention (but not CST), and social activities.

Study Details

The goal of this mixed method study is to evaluate whether the volunteer-led Cognitive Stimulation Therapy (CST) under the BrainLive Connect programme is effective for improving cognitive function and quality of life of people living with dementia (PLwD). The main question it aims to answer are: • Do PLwD receiving the BrainLive Connect service show better cognitive function and quality of life than those receiving usual care? Researchers will compare BrainLive Connect service to usual care to see whether the intervention leads to better outcomes. Participants will: * Receive either 7 weeks of BrainLive Connect sessions delivered by trained volunteers or continue receiving usual care. * Be assessed at baseline (T0), post-intervention (7 weeks; T1), and 1 month follow up (11 weeks; T2). * Take part in semi-strucutred interviews post-intervention to provide feedback on implementation and areas for improvement.

Key Dates

First listed
Apr 15, 2026
Start date
Mar 31, 2026
Status verified
Mar 2026
Primary completion
Nov 10, 2027
Completion
Nov 10, 2027

Study Design

Enrollment
520 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Non-professional delivered CST
    Participants will receive 14-session Cognitive Stimulation Therapy (CST) delivered by trained volunteers, with two sessions per week over a period of 7 weeks
  • Active Comparator: Usual social care
    Participants will receive usual social care and support provided by elderly care service units operated by non-governmental organisations, including but not limited to care services, psychosocial intervention, and social activites.

Primary Outcome Measure

The Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) [ Time Frame: Intake (T0), a 7-week follow-up (T1), and a one-month follow-up (T2) ]

Central Contacts

Related Studies